Volume 25, Number 12—December 2019
Synopsis
Global Epidemiology of Buruli Ulcer, 2010–2017, and Analysis of 2014 WHO Programmatic Targets
Table 2
Region and country | Total no. cases, 2011–2017 | 2017 data |
||||||
---|---|---|---|---|---|---|---|---|
No. suspected cases |
Incidence, cases/100,000 population | Patients age <15 y, % | Female patients, % | Lesion located on lower limb, % | Completed antimicrobial therapy, % | |||
2010 | 2017 | |||||||
AFRO region | ||||||||
Benin | 572 | 267 | 3,027 | 2.35 | 41 | 50.5 | 61† | 100† |
Cameroon | 287 | No data | 1,180 | No data | 31† | 49† | 74† | 99† |
Congo | 107 | No data | 207 | No data | No data | No data | No data | No data |
Côte d'Ivoire | 2,533 | 344 | 8,713 | 1.31 | 48 | 52 | 57† | 100† |
DRC | 136 | 91 | 1,535 | 1.80 | 33† | 44† | 72† | 100† |
Gabon | 65 | 45 | 402 | 2.12 | 40 | 49 | 77† | 84 |
Ghana | 1,048 | 538 | 4,828 | 1.91 | 13 | 48 | 83† | No data |
Guinea | 24 | 98 | 549 | 0.83 | 14† | No data | No data | No data |
Liberia | No data | 219 | 353 | 4.55 | 14 | 47 | No data | 57 |
Nigeria | 7 | 259 | 747 | 0.13 | 50 | 57 | 78† | 94 |
Sierra Leone | No data | No data | 28 | No data | No data | No data | No data | No data |
South Sudan | 4 | No data | 4 | No data | No data | No data | No data | No data |
Togo | 67 | 62 | 500 | 0.76 | 53 | 42 | 54† | 86† |
AFRO subtotal‡ |
4,850 |
1,923 |
22,073 |
31 |
50 |
71 |
70 |
|
WPRO region | ||||||||
Australia | 42 | 283 | 1,033 | 1.21 | 10 | 48 | 58 | 100† |
Japan | 9 | 6 | 52 | 0.0048 | 17 | 67 | 50† | 100 |
Papua New Guinea | 5 | 5 | 48 | 0.07 | 80 | 60 | ||
WPRO subtotal‡ |
56 |
294 |
1,133 |
11 |
49 |
58 |
100 |
|
Global total | 4,906 | 2,217 | 23,196 | 26 | 50 | 69 | 74 |
*Data from Buruli ulcer–endemic countries that reported continuous data for most of the years assessed. Up-to-date country data on annual reported cases are available at http://apps.who.int/gho/data/node.main.A1631. AFRO, WHO African Region; DRC, Democratic Republic of the Congo; WPRO, WHO Western Pacific Region; WHO, World Health Organization.
†2016 data; 2017 data were not available.
‡Cases and total cases represent sums of countries per region. Programmatic indicators represented mean proportions weighted for case burden in the respective countries.
Page created: November 18, 2019
Page updated: November 18, 2019
Page reviewed: November 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.